Medicare Enrolled
Dr. Farooq Hassan, MD
Rheumatology · Hermitage, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hassan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hassan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hassan
Dr. Farooq Hassan is a rheumatology specialist in Hermitage, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hassan performed 166,684 Medicare services across 3,430 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hassan received a total of $27,992 from 46 pharmaceutical and/or device companies across 1757 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hassan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in PA
$27,992 industry payments
Medicare Practice Summary
Medicare Utilization ↗166,684
Medicare services
Top 7% in PA for rheumatology
3,430
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~8,334 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
119,400 | $4 | $14 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
20,650 | $33 | $72 |
| Denosumab injection (Prolia/Xgeva) | 10,261 | $18 | $30 |
| Joint lubricant injection (Gel-Syn) An injection of hyaluronan or its derivative into a joint space to supplement joint fluid. |
9,072 | $1 | $4 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
1,371 | $17 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,118 | $88 | $172 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
591 | $54 | $122 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
444 | $11 | $25 |
| Cardiolipin antibody (tissue antibody) measurement | 441 | $25 | $50 |
| Beta 2 glycoprotein 1 antibody (autoantibody) measurement | 438 | $25 | $56 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
406 | $97 | $390 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
295 | $1 | $12 |
| Rheumatoid factor level | 223 | $6 | $15 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
222 | $29 | $60 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
222 | $13 | $30 |
| Measurement of dna antibody, single stranded | 196 | $12 | $30 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
195 | $13 | $30 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
188 | $11 | $54 |
| Microsomal antibody test A blood test that measures the level of microsomal antibodies, which are autoantibodies produced by the immune system. |
181 | $14 | $35 |
| Tuberculosis test, enumeration of t-cells A blood test that counts T-cells to help detect tuberculosis infection. |
165 | $97 | $200 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
154 | $49 | $214 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
125 | $37 | $240 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $45 | $114 |
| New patient office visit, complex (60-74 min) | 79 | $148 | $334 |
| Injection, methylprednisolone acetate, 40 mg | 38 | $5 | $17 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
34 | $39 | $98 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
32 | $4 | $15 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $140 | $232 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
15 | $38 | $94 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
13 | $41 | $242 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
13 | $49 | $198 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.6% high complexity
84.0% medium
3.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$27,992
Total received (2018-2024)
Avg $3,999/year across 7 years
Top 16% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
1,757
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,992 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,844
2023
$4,496
2022
$4,287
2021
$4,353
2020
$2,555
2019
$3,921
2018
$3,537
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$801
Amgen Inc.
$705
Janssen Biotech, Inc.
$688
UCB, Inc.
$617
Novartis Pharmaceuticals Corporation
$398
PFIZER INC.
$326
AstraZeneca Pharmaceuticals LP
$214
GlaxoSmithKline, LLC.
$208
E.R. Squibb & Sons, L.L.C.
$191
Lilly USA, LLC
$138
Janssen Scientific Affairs, LLC
$98
Kiniksa Pharmaceuticals International, plc
$86
Fresenius Kabi USA, LLC
$81
Organon Llc
$77
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Bioventus LLC
$62
ANI Pharmaceuticals, Inc.
$32
SOBI, INC
$21
Genentech USA, Inc.
$13
Actelion Pharmaceuticals US, Inc.
$13
Top 3 companies account for 45.3% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$4,716
Amgen Inc.
$4,602
UCB, Inc.
$2,880
ABBVIE INC.
$2,437
PFIZER INC.
$1,912
Novartis Pharmaceuticals Corporation
$1,750
Lilly USA, LLC
$1,208
E.R. Squibb & Sons, L.L.C.
$779
GlaxoSmithKline, LLC.
$768
AbbVie Inc.
$706
AbbVie, Inc.
$615
AstraZeneca Pharmaceuticals LP
$526
Boehringer Ingelheim Pharmaceuticals, Inc.
$510
Horizon Therapeutics plc
$491
Genentech USA, Inc.
$385
Janssen Scientific Affairs, LLC
$341
Celgene Corporation
$314
Mallinckrodt Hospital Products Inc.
$278
Horizon Pharma plc
$262
Radius Health, Inc.
$221
Flexion Therapeutics, Inc.
$220
ANI Pharmaceuticals, Inc.
$211
Mallinckrodt Enterprises LLC
$209
Actelion Pharmaceuticals US, Inc.
$184
Mallinckrodt LLC
$164
Bioventus LLC
$139
Antares Pharma, Inc.
$136
Fresenius Kabi USA, LLC
$118
Aurinia Pharma U.S., Inc.
$98
Alexion Pharmaceuticals, Inc.
$94
Kiniksa Pharmaceuticals International, plc
$86
Organon Llc
$77
Kiniksa Pharmaceuticals, Ltd.
$75
Regeneron Healthcare Solutions, Inc.
$74
Hikma Pharmaceuticals USA
$64
West-Ward Pharmaceuticals
$61
MEDEXUS PHARMA, INC.
$56
Shield Therapeutics Inc
$42
SOBI, INC
$36
Sebela Pharmaceuticals Inc.
$35
Sobi, Inc
$32
kaleo, Inc.
$24
Ultragenyx Pharmaceutical Inc.
$17
Mission Pharmacal Company
$14
MEDAC PHARMA, INC.
$13
Abbott Laboratories
$11
Top 3 companies account for 43.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AMJEVITA · AVSOLA · Actemra · Aquoral · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · Durolane · EVENITY · EVUSHELD · EVZIO · Enbrel · FORTEO · GELSYN-3 · HADLIMA · HUMIRA · Humira · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · LEQVIO · LUPKYNIS · LYRICA · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · OTREXUP · Otezla · Otrexup · PAXLOVID · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SCS leads · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · UPTRAVI · Ultomiris · VIMOVO · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
7
Per 100K population
6.4
County median income
$60,614
Nearest hospital
SHARON REGIONAL MEDICAL CENTER
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hassan is a mixed practice specialist, with above-average Medicare volume (top 7% in PA), with low-engagement industry engagement in the top 16% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hassan experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Hassan performed 119,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hassan receive payments from pharmaceutical companies?
Yes. Dr. Hassan received a total of $27,992 from 46 companies across 1,757 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hassan's costs compare to other rheumatologists in Hermitage?
Dr. Hassan's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hassan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Hermitage
Browse rheumatologists in Hermitage ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in PA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in PA
Which PA rheumatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology